Context Therapeutics Inc. is a biopharmaceutical company focused on advancing innovative treatments for women's cancers

The company specializes in developing targeted therapeutics that aim to address the unique challenges and unmet needs in the treatment of gynecologic cancers, including ovarian and endometrial cancer. By harnessing advanced research and proprietary technologies, Context Therapeutics is committed to improving patient outcomes through the creation of personalized therapies that enhance the efficacy and safety of cancer treatment options.